The Alldus Podcast - AI in Action

Today's guest is Jeremy Baksht, SVP of Alternative Data at Ascential in New York. Jeremy is an experienced capital market professional with twenty years in the industry as an investment banker, business consultant, FinTech entrepreneur and angel investor. Jeremy is currently the global head of alternative data at Ascential, the leading specialist information public company covering the digital economy. Ascential works with the world’s best consumer brands and their ecosystems, connecting them with their customers throughout the purchase journey. Jeremy leads Ascential’s efforts to sell their offerings to financial services clients. Their team has expertise at pricing, sales and share, and consumer perception in sectors such as apparel, grocery and CPG. Ascential's data sets include several years of history and can be utilized to build robust financial models well beyond those typically available in current investment research. In the show. Jeremy will discuss: His background and his current work at Ascential, Exciting use cases of how they help clients in the consumer space, Helping clients maximise their data to gain ROI, The impact of Data Science & Machine Learning at Ascential, What he loves about working in Alternative Data, What's in store for the future, and Top advice on transitioning into a role within Alternative Data

Welcome the very first episode in our very special Cybersecurity series of the AI in Action podcast.  Today's guest is Clodagh Durkin. Clodagh has over 23 years experience in Cybersecurity and the majority of this time has been spent in Senior and Leadership roles. Based in Germany for the last number of years, Clodagh has some great insights on the international cybersecurity market with specific emphasis on Digital Trust. This conversation touches upon local and corporate level precautions taken to maintain this trust. In the show, Clodagh will discuss: Her background working in the Telecoms sector, Ensuring digital trust among customers, How innovation has brought Cybersecurity to the mainstream, The impact of GDPR in the industry, How to prepare and react for data breaches, and her Advice to those looking for a career in Cybersecurity

Today's guest is Peter Hafez, Chief Data Scientist at RavenPack, who are the leading big data analytics provider for financial services. The company’s products allow clients to enhance returns, reduce risk or increase efficiency by incorporating the effects of public information in their models or workflows. RavenPack’s clients include the most successful hedge funds, banks and asset managers in the world. Peter is responsible for setting up and managing the company’s Data Science department, which is instrumental in the design and development of new products derived from RavenPack's Big Data Analytics platform. With backgrounds in image processing, mathematics, machine learning and econometrics; the team is responsible for researching and modelling big data applications for the financial markets. In the show, Peter will discuss: RavenPack’s impact in the Fintech industry, Benefits their products bring to customers, Interesting projects they are working on within data, Building a successful infrastructure, Why he loves working at RavenPack, and Interesting projects coming up in the near future

Today's guest is Geetu Ambwani, Senior Director of Data Insights at Flatiron Health in New York. Their mission is to improve lives by learning from the experience of every cancer patient. What stands in the way is that much of the available, real-world clinical data is unstructured and stored across thousands of disconnected community clinics, medical centers and hospitals but this is a problem that Flatiron believe they can solve. Geetu is deeply interested in the art and science of applying machine learning and data science techniques to formulate and help solve hard problems in the healthcare space. Over the last 15 years, she has worked successfully at the intersection of data science and product development and is constantly driven to find new insights into text, semi-structured, and structured data. She also enjoys participating in conferences and panels organized by the NYC tech and data community. In the show, Geetu will discuss: Flatiron’s impact in the healthcare sector, The role of the Data Insights function, Interesting projects within drug discovery for cancer patient care, How they set up a successful Data Science team, Transitioning her skills from media into Healthtech, and What the future looks like at Flatiron Health

Today's guest is André Cohen, Head of Data Science at Tilting Point in New York. Tilting Point is a new-generation games partner for top independent development studios, with a focus on the rapidly growing mobile and tablet markets. André brings 10 years of game industry experience with expertise in machine learning, dynamic pricing, game optimization and game development. Tilting Point empowers elite developers with expert resources, operational support and funding to give carefully selected games mainstream success. The company adheres to a core philosophy of putting development talent first, advancing industry-leading analytics and overcoming discoverability hurdles with aggressive, best-in-class marketing. In the show, André will discuss: Deciding to drop out of his PhD to pursue his passion for gaming, What he learned in his experience with White Shoe Media & Gondola, The exciting work he does with Tilting Point, The importance of Data Analytics within mobile gaming, Use cases of the success they bring to game developers, The impact of Data Science & Business Intelligence at Tilting Point, and How Data Science will further impact the gaming sector

Today's guest is Melissa Landon, VP and Chief Strategist at Cyclica. Cyclica is a Toronto-Based globally recognized biotechnology company that leverages AI and computational biophysics to reshape the drug discovery process. Cyclica's proprietary structure-based and AI-augmented drug discovery platform includes Ligand Design for multi-targeted and multi-objective drug design, and Ligand Express for off-target profiling, systems biology linkages, and structural pharmacogenomic insights. Taken together, Ligand Design and Ligand Express design advanced lead-like molecules that minimize unwanted off-target effects, while providing a holistic understanding of a molecule's activity through integrated systems biology and structural pharmacogenomics. By doing more with Artificial Intelligence, Cyclica aims to revolutionize a system troubled with attrition and costly failures, accelerate the drug discovery process and develop medicines with greater precision. In the show, Melissa will tell you about: The fascinating work they are providing in the biotech industry, What makes them stand out from the competition, How they are applying Machine Learning and Data Science at Cyclica, What attracted her to join Cyclica, Upcoming projects & what’s in store for the future, and How AI & Data Science will continue to positively disrupt the HealthTech sector.

On today's show, host JP Valentine chats with Dave Boerner, Director of Data Strategy at Particle Health in New York.  Founded in 2017, Particle Health is on a mission to solve the biggest problem facing the American healthcare system - data sharing. They believe patients have the right to control their data, but shouldn’t bear the responsibility of collecting, managing and transporting it. That’s where Particle Health comes in. By taking a unique approach, their venture-backed startup is positioned to lead patient-centric data sharing. Particle Health manages patient consent, giving investigators, underwriters and administers a single-point ‘clearinghouse’ for clinical health data, without the need for a 3rd party. With Particle Health, simply obtain a patient's permission to securely access their digital medical records. It's that easy. In the show, Dave will tell you about: The interesting projects going on at Particle Health, How they are improving data access within healthcare data, Using data to improve cover, reduce costs and improve outcomes, What they look for when scaling their team, Benefits that Particle Health can bring to clients, Advice to those looking to start their Data Science career, and What’s in store for the future at Particle Health

In today's episode, host JP Valentine chats with Stuart Mason, Manager of Data Science at Anvyl in New York. Anvyl believes that a fully digital, perfectly transparent supply chain is as important to a brand’s success as the business model itself. Anvyl is a production hub where brands can manage suppliers, oversee production and track in-depth product data from procurement to delivery of inbound goods. They help brands supply their customers with what they want, when they want it and improve their bottom line at the same time. Stuart has a passion for statistical computing and using mathematics to describe and understand the real world. He likes drawing inferences from large datasets, creating simplified takeaways and producing information-rich visualizations. Stuart also likes to teach and share knowledge, which has led him to develop employees under his leadership into strong team contributors. In the show, Stuart will discuss: How Anvyl are impacting the supply chain, What he has learned during his time with Anvyl, How the COVID-19 pandemic is disrupting the sector, How Data Science will continue to help evolve the company, Traits they look for in hiring Data Scientists and What’s in store for the future at Anvyl

In this episode, host JP Valentine sits down with Rohit Nambisan, President at Lokavant in New York. Lokavant is a technology company whose mission is to ensure that no clinical trial fails due to operational error. By integrating and analyzing the disparate data sources within clinical trials, Lokavant provides real-time visualizations and risk alerts to study sponsors and CROs to enable data-driven decisions. These insights expedite trial timelines and reduce the costs of development, allowing safe and efficacious treatments to get to patients. Lokavant centralizes trial data to power a machine learning model that anticipates trial risk, provides data-driven risk mitigation strategies and predicts the impact of mitigation strategy implementation. Lokavant's anticipatory monitoring capability is grounded in a compendium of data from over 1,000 clinical trials and will improve with each deployment. In the show, Rohit will share with you: How Lokavant aim to impact the Healthcare sector, Using data to positively impact clinical trials, How the Coronavirus pandemic is disrupting clinical trials, Lokovant’s solutions in response to COVID-19, Why he loves working in the Healthtech industry, and What the future looks like for Lokavant

Today's guest is Georgios Ouzounis, VP of Data Science at ElectrifAi. Georgios is a technology expert and thought leader with over 20 years of engineering, research and project management experience. He has great experience driving innovation and business growth in multiple sectors, through data-driven strategic insights, Data Science, Computer Vision, Machine Learning and AI at scale. Founded in 2004, ElectrifAi is a global leader in building innovative AI-based solutions and is on a mission to help organizations solve their most pressing and difficult problems through the power of AI and Machine Learning. It is ElectrifAi's mission to make AI more understandable, accessible and profitable for businesses all over the world. In the show, Georgios will share with you: The interesting products ElectrifAi are developing to the market, Exciting projects in medical imaging and COVID-19 solutions, His role within Computer Vision and Machine Learning, Building the ideal Data Science team, How data will improve their products for the healthcare industry, Challenges to overcome working with medical data, & What’s in store for the future at ElectrifAi